Good morning :)
Place Order
Add to Watchlist

Aprameya Engineering Ltd

APRAMEYA

Aprameya Engineering Ltd

APRAMEYA
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹228 cr, stock is ranked 2,403
High RiskStock is 4.63x as volatile as Nifty
120.250.38% (+0.45)
120.250.38% (+0.45)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹228 cr, stock is ranked 2,403
High RiskStock is 4.63x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹228 cr, stock is ranked 2,403
High RiskStock is 4.63x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
9.80
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aprameya Engineering Limited is an India-based healthcare solution provider operating in trading of medical support equipment and supplies for infra projects of healthcare sectors.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue12.3226.0135.0478.3365.62
Raw Materialssubtract8.879.303.798.0912.28
Power & Fuel Costsubtract0.020.010.000.040.05
Employee Costsubtract1.791.910.832.582.71
Selling & Administrative Expensessubtract1.2010.4117.8356.1237.15
Operating & Other expensessubtract-1.241.902.491.856.61
Depreciation/Amortizationsubtract0.070.090.020.100.11
Interest & Other Itemssubtract0.900.870.142.082.11
Taxes & Other Itemssubtract0.060.672.472.111.14
EPS0.871.056.593.832.47
DPS0.000.000.000.000.00
Payout ratio0.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHealth Care Equipment & Supplies

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Aprameya Engineering Ltd66.179.80
Inventurus Knowledge Solutions Ltd96.5330.890.48%
Poly Medicure Ltd98.2217.260.11%
Tarsons Products Ltd48.703.390.51%

Price Comparison

Compare APRAMEYA with any stock or ETF
Compare APRAMEYA with any stock or ETF
APRAMEYA
Loading...

Shareholdings

Promoter Holdings Trend

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.68%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.53%0.00%5.38%2.47%18.62%

Sep 2022

Jul 2024

Sep 2024

Shareholding History

SepJulSep0.00%4.15%2.47%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

APRAMEYA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Aprameya Engineering schedules board meeting

Aprameya Engineering will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
NSE SME Aprameya Engineering makes a strong debut

The scrip was listed at Rs 72, a premium of 24.14% over the initial public offer (IPO) price. The stock is currently frozen in its upper limit of 5% over its listing price. The counter hit a high of Rs 75.60 and a low of Rs 72. About 15.38 lakh shares of the company changed hands at the counter. Aprameya Engineering's IPO was subscribed 128.12 times. The issue opened for bidding on 25 July 2024 and it closed on 29 July 2024. The price band of the IPO was set at Rs 56 to Rs 58 per share. The IPO comprised fresh issue of 50,40,000 shares. The promoter and promoter group shareholding diluted to 73.53% from 100% pre-IPO. The company intends to utilize the net proceeds to meet incremental working capital requirements and general corporate purpose. Ahead of the IPO, Aprameya Engineering on 24 July 2024, raised Rs 8.31 crore from anchor investors. The board allotted 14.34 lakh shares at Rs 58 per share to 7 anchor investor. Aprameya Engineering is a healthcare infrastructure company specializing in setting up and maintaining critical care units like ICUs, NICUs, and PICUs. They also construct operation theaters, dialysis centers, and prefabricated wards. In addition, they supply high-tech medical equipment like patient monitoring systems, cardiology devices, and radiology equipment to hospitals. As of June 2024, the company has 43 employees. The company recorded revenue from operations of Rs 65.16 crore and net profit of Rs 3.45 crore for the period as on 31 March 2024. Powered by Capital Market - Live

4 months agoCapital Market - Live